---
figid: PMC9320700__curroncol-29-00389-g002
figtitle: 'Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?'
organisms:
- Homo sapiens
- Mus musculus
- Caenorhabditis elegans
- Sequoia sempervirens
organisms_ner:
- Homo sapiens
- Mus musculus
pmcid: PMC9320700
filename: curroncol-29-00389-g002.jpg
figlink: /pmc/articles/PMC9320700/figure/curroncol-29-00389-f002/
number: F2
caption: Factors decreasing CTL cell activity. Cancer cells express inhibitory molecule
  PD-L1, which binds to PD-1 on CTLs. This binding induces a negative regulatory pathway
  that limits CTL activity. Other inhibitory immune checkpoints, such as CTL-A4, and
  immunosuppressing molecules (i.e., IL-10, TGF-β, IDO) could also negatively impact
  CTL activity.
papertitle: 'Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?.'
reftext: Liqin Yao, et al. Curr Oncol. 2022 Jul;29(7):4902-4913.
year: '2022'
doi: 10.3390/curroncol29070389
journal_title: Current Oncology
journal_nlm_ta: Curr Oncol
publisher_name: MDPI
keywords: breast cancer | cytotoxic T lymphocytes (CTLs) | Human Leukocyte Antigen-DR
  (HLA-DR) | neoadjuvant chemotherapy (NACT) | pathologic complete response (pCR)
  | tumor-infiltrating lymphocytes (TILs)
automl_pathway: 0.88349
figid_alias: PMC9320700__F2
figtype: Figure
redirect_from: /figures/PMC9320700__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9320700__curroncol-29-00389-g002.html
  '@type': Dataset
  description: Factors decreasing CTL cell activity. Cancer cells express inhibitory
    molecule PD-L1, which binds to PD-1 on CTLs. This binding induces a negative regulatory
    pathway that limits CTL activity. Other inhibitory immune checkpoints, such as
    CTL-A4, and immunosuppressing molecules (i.e., IL-10, TGF-β, IDO) could also negatively
    impact CTL activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD8A
  - CD8B
  - CTLA4
  - IDO1
  - IL10
  - TGFB1
  - TGFB2
  - TGFB3
  - Cd274
  - Pdcd1
  - Ctla4
  - Ido1
  - Il10
  - Tgfb1
  - Ltbp1
---
